ACOR - Acorda Therapeutics Inc
IEX Last Trade
17.26
-0.340 -1.970%
Share volume: 11,619
Last Updated: Tue 08 Aug 2023 06:55:10 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$17.60
-0.34
-1.93%
Summary score
10%
Profitability
0%
Dept financing
25%
Liquidity
36%
Performance
10%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.42%
Return on assets
-2.89%
Return on sales
-52.33%
Return on invested capital
-5.8%
Total debt ratio
69.15%
Debt ratio change over timeo
-9.78%
Current Ratio
1.76%
Quick Ratio
1.43%
Cash Position Ratio
0.76%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.58%
Return on assets
-1.4%
Return on sales
-31.38%
Return on invested capital
-1.58%
Total debt ratio
80.28%
Debt ratio change over timeo
-19.72%
Current Ratio
1.96%
Quick Ratio
1.56%
Cash Position Ratio
0.85%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-15.08%
Return on assets
-2.11%
Return on sales
-27.86%
Return on invested capital
-3.61%
Total debt ratio
83.91%
Debt ratio change over time
-24.25%
Current Ratio
1.59%
Quick Ratio
1.21%
Cash Position Ratio
0.7%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-95.42%
Return on assets
-73.45%
Return on sales
371.95%
Return on invested capital
-123.8%
Total debt ratio
-978.11%
Debt ratio change over time
-9.78%
Current Ratio
-29.45%
Quick Ratio
-24.81%
Cash Position Ratio
-15.79%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACOR | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -12.42% | -2.6% | -14.24% | 0% |
| Return on assets | -2.89% | -2.4% | -12.07% | 0% |
| Return on sales | -52.33% | -25.64% | 0% | 0% |
| Return on invested capital | -5.8% | -55.3% | -26.3% | 0% |
| Profitability | 0% | 0% | 25% | 75% |
| Total debt ratio | 69.15% | 19.36% | 16.14% | 0% |
| Debt ratio change over time | -9.78% | -1.42% | -1.73% | 0% |
| Dept financing | 25% | 7% | 6% | 25% |
| Current Ratio | 1.96% | 3.26% | 0% | 0% |
| Quick Ratio | 1.56% | 2.66% | 0% | 0% |
| Cash Position Ratio | 0.85% | 1.8% | 0% | 0% |
| Liquididy | 24% | 74% | 50% | 0% |
| Short-term ratios | ACOR | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -7.58% | -7.06% | 0% | 0% |
| Return on assets | -1.4% | -5.52% | 0% | 0% |
| Return on sales | -31.38% | -34.22% | 0% | 0% |
| Return on invested capital | -1.58% | -154.82% | 0% | 0% |
| Profitability | 0% | 0% | 100% | 0% |
| Total debt ratio | 80.28% | 25.43% | 0% | 0% |
| Debt ratio change over time | -19.72% | -1.21% | 0% | 0% |
| Dept financing | 25% | 8% | 25% | 0% |
| Current Ratio | 1.96% | 3.26% | 0% | 0% |
| Quick Ratio | 1.56% | 2.66% | 0% | 0% |
| Cash Position Ratio | 0.85% | 1.8% | 0% | 0% |
| Liquididy | 41% | 75% | 0% | 0% |